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Abstract
Background The Tokyo Guidelines for the management
of acute cholangitis and cholecystitis were published in
2007 (TG07) and have been widely cited in the world lit-
erature. Because of new information that has been pub-
lished since 2007, we organized the Tokyo Guidelines
Revision Committee to conduct a multicenter analysis to
develop the updated Tokyo Guidelines (TG13).
Methods/materials We retrospectively analyzed 1,432
biliary disease cases where acute cholangitis was sus-
pected. The cases were collected from multiple tertiary
care centers in Japan. The ‘gold standard’ for acute cho-
langitis in this study was that one of the three following
conditions was present: (1) purulent bile was observed; (2)
clinical remission following bile duct drainage; or (3)
remission was achieved by antibacterial therapy alone, in
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patients in whom the only site of infection was the biliary
tree. Comparisons were made for the validity of each diag-
nostic criterion among TG13, TG07 and Charcot’s triad.
Results The major changes in diagnostic criteria of TG07
were re-arrangement of the diagnostic items and exclusion of
abdominal pain from the diagnostic list. The sensitivity
improved from 82.8 % (TG07) to 91.8 % (TG13).
While the specificity was similar to TG07, the false positive
rate in cases of acute cholecystitis was reduced from 15.5 to
5.9 %. The sensitivity of Charcot’s triad was only
26.4 % but the specificity was 95.6 %. However, the false
positive rate in cases of acute cholecystitis was 11.9 % and
not negligible. As for severity grading, Grade II (moderate)
acute cholangitis is defined as being associated with any two
of the significant prognostic factors which were derived from
evidence presented recently in the literature. The factors
chosen allow severity assessment to be performed soon after
diagnosis of acute cholangitis.
Conclusion TG13 present a new standard for the diagnosis,
severity grading, and management of acute cholangitis.
Keywords Acute cholangitis  Biliary infection 
Diagnostic criteria  Severity assessment  Charcot’s triad
Introduction
Patients with acute cholangitis are at risk for developing
severe infection that can be fatal unless appropriate medical
care is provided at an early stage. Advances in antibiotic
therapy and acute care as well as a wide diffusion of expertise
in biliary endoscopy have resulted in reduction of morbidity
and mortality from acute cholangitis. However, it remains a
life-threatening disease and early determination of disease
severity is essential to select appropriate therapy, particu-
larly the timing of biliary decompression. In 2007, we con-
ducted a systematic review and sponsored an international
consensus conference in Tokyo. This meeting resulted in the
introduction of the new Tokyo Guidelines (TG07) for diag-
nosis and severity assessment of acute cholangitis [1].
Diagnostic and severity assessment criteria need to be
updated periodically based on new information, criticisms,
and suggestions for improvement. For instance, ever since
Charcot reported a patient with severe acute cholangitis as
a case of ‘hepatic fever’ in 1877, Charcot’s triad has been
widely considered to be one of the most important diag-
nostic criteria [2–6]. However, Charcot’s triad has extre-
mely low sensitivity despite its high specificity. In addition,
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false positive cases of acute cholecystitis are not unusual
with this classic diagnostic triad.
With experience we and others found potential short-
comings in TG07 [7]. Consequently, the Tokyo Guidelines
Revision Committee was assembled and gathered a large
number of cases of acute cholangitis from tertiary care
centers in Japan. These cases acted as a gold standard to
assess diagnostic and severity criteria such as TG07. The
present study has confirmed limitations of TG07 and pre-
sents updated TG13 criteria which have improved sensi-
tivity and specificity and which importantly, unlike the
criteria in TG07, allow severity assessment at the time of
presentation so that biliary drainage or other procedures
can be performed without delay.
Methods
In the present multicenter study, 1,432 patients were
enrolled with biliary tract abnormalities and suspected
acute cholangitis between January 2007 and July 2011.
Choledocholithisis or biliary stricture was confirmed by
direct cholangiography (i.e., endoscopic retrograde chol-
angiopancreatography (ERCP), percutaneous transhepatic
cholangiography). Acute cholecystitis was confirmed by
pathologic examination of excised gallbladders.
The establishment of guidelines for diagnosis and severity
assessment in a disease requires that there is diagnostic
certainty by which to assess criteria. For acute cholecystitis
this may be provided by pathologic examination of excised
gallbladders; however, pathologic specimens are not avail-
able in acute cholangitis. Our approach in this study was to
gather data from 794 patients who were considered to have
had acute cholangitis based on one of the following three
criteria: (1) presence of purulent biliary leakage; (2) clinical
remission due to bile duct drainage; or (3) remission
achieved by antimicrobial therapy alone in patients in whom
the only site of infection was the biliary tree. For comparison
we also gathered data from 638 patients who had other biliary
tract abnormalities (Table 1).
Using these patients, we adjusted diagnostic criteria to
have the highest sensitivity and specificity for acute cho-
langitis. For establishment of new severity assessment
criteria, we examined variables reported in the literature
either as predictive of poor prognosis in acute cholangitis
or of need for urgent biliary drainage (Table 2). These
Table 2 Prognostic factors in acute cholangitis
Prognostic factor Positive value References
Hyperbilirubinemia [2 mg/dL [8]
[2.2 mg/dL [9]
[2.93 mg/dL [10]
[4 mg/dL [11, 12]
[5.26 mg/dL [13]
[5.56 mg/dL [14]
[8.1 mg/dL, [9.2 mg/
dL
[15]
[9.1 mg/dL [16]
[10 mg/dL [17]
Hypoalbuminemia \3.0 g/dL [10, 13, 18]
Acute renal failure BUN ([20–[64 mg/dL)
Creatinine ([1.5–
[2.0 mg/dL)
[8, 9, 11, 19,
20]
Shock [8, 12, 13, 19]
Reduced platelet count \1,00,000–\1,50,000/
mm3
[13, 18, 20]
Endotoxemia/
bacteremia
[9, 10, 14, 20]
High fever [38 C [8]
[39 C [12]
[40 C [16]
Medical comorbidity [8, 11, 13, 18,
19]
Elderly patient C50 years old [11]
C60 years old [8]
C70 years old [19, 21]
C75 years old [22]
Malignancy as etiology [9, 11, 14]
Prolonged prothrombin
time
B14 s [10, 22]
B15 s [8]
Leukocytosis B12,000 [8]
B20,000 [16, 17]
Current smoking Yes [21, 22]
Table 1 Clinical characteristics of patients
Acute cholangitis
(n = 794)a
Other disease (n = 638)
Etiology;
choledocholithiasis
(n = 402)
malignant tumor
(n = 392)
Choledocholithiasis (n = 178),
obstructive jaundice caused by
malignant tumor (n = 241)
acute cholecystitis (n = 219)
Age 71.7 ± 11.8 68.5 ± 12.3
Sex
(male:female)
490:304 307:331
Charcot triad 147 (18.5 %) 26 (4.1 %)
Abdominal
pain
435 (54.8 %) 309 (48.4 %)
Presence of purulent biliary leakage
Clinical remission due to bile duct drainage
Remission achieved by antimicrobial therapy alone in patients in
whom the only site of infection was the biliary tree
a The ‘Gold Standard’ for acute cholangitis in this study was that one
of the following three conditions was present
550 J Hepatobiliary Pancreat Sci (2012) 19:548–556
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variables were then used to construct a grading system that
would permit determination of the level of severity at the
time of diagnosis so that those patients who need urgent
biliary decompression could receive treatment without
delay.
For confirming the advantage of these revisions, updated
diagnostic criteria and severity assessment criteria also
were retrospectively assessed by the present multicenter
analysis.
Results
Formulation of new diagnostic criteria for acute
cholangitis
Assessment of Charcot’s triad and TG07 diagnostic
criteria for acute cholangitis
Analysis of the 1,432 cases of biliary tract diseases showed
that Charcot’s triad had low sensitivity (26.4 %) but high
specificity (95.9 %) for acute cholangitis, with 11.9 % of
cases of acute cholecystitis demonstrating Charcot’s triad.
On the other hand, the sensitivity and specificity of TG07
diagnostic criteria were 82.6 and 79.8 %, respectively,
while 11.9 % of cases acute cholecystitis would have fit the
diagnostic criteria for acute cholangitis if TG07 criteria
were applied (Table 3). Furthermore, TG07 diagnostic
criteria for acute cholangitis were found to have insuffi-
cient sensitivity for making an early diagnosis of life-
threatening acute cholangitis.
Revision of TG07 diagnostic criteria for acute cholangitis
It seemed that the shortcomings of TG07 might be
related to inappropriate combination of such items as
clinical context and manifestations, laboratory data and
imaging findings. Therefore, for TG13, categories of
diagnostic items were constructed based on the three
main clinical manifestations used in the diagnosis of acute
cholangitis: (a) fever and/or evidence of inflammatory
response, (b) jaundice and abnormal liver function tests, and
(c) abdominal pain, a history of biliary diseases, biliary
dilatation, or other biliary manifestations. The presence of a
finding in all three of these categories has been considered
to be diagnostic of acute cholangitis.
Abdominal pain and a history of biliary tract disease,
however, are also common indicators of other biliary
problems such as acute cholecystitis and even acute hep-
atitis. Acute cholecystitis application of the first draft cri-
teria of TG13 (which included abdominal pain and a
history of biliary tract disease) to patients with acute cho-
lecystitis resulted in 38.8 % of patients with acute chole-
cystitis meeting the criteria for diagnosis of acute
cholangitis. However, despite a high sensitivity for acute
cholangitis of 95.1 % for these diagnostic criteria the
specificity of (66.3 %) was disappointingly low (Table 3).
In the next iteration of the diagnostic criteria, abdominal
pain and the history of biliary diseases were deleted from
the diagnostic criteria. This resulted in the best outcome in
terms of high sensitivity and specificity for acute cholan-
gitis and low false positive rate for acute cholecystitis
(Table 3) and these were the diagnostic criteria which were
adopted for TG13 (Table 3).
The final TG13 diagnostic criteria are shown in Table 4.
To make a definitive diagnosis one item from each of the
three categories (A–C) is required. Furthermore, a ‘sus-
pected’ diagnosis can be made when there is one item
present from the A list and one item from either the B or C
list. By establishing ‘suspected diagnosis’, early biliary
drainage or source control of infection among patients with
acute cholangitis can be provided without waiting for a
definitive diagnosis.
One of the items in category A involves determination
of the presence of abnormal laboratory tests. Thresholds for
declaring positivity test might be set at the upper limit of
normal for the tests. The disadvantage of this approach is
that minor abnormalities in the tests are not uncommon in
acute cholecystitis. Therefore, a somewhat higher threshold
for acute cholangitis is desirable. The normal upper limit
range of the liver function tests differs from facility to
facility. Therefore, a fixed threshold is not practical.
Instead, the threshold was set at 1.5 times the upper limit of
normal in a facility. We then conducted a multicenter
analysis to compare this threshold with two other types of
threshold in terms of the diagnostic ability for acute cho-
langitis. When the threshold was set at 1.5 times the upper
limit, both sensitivity and specificity were similar to those
at which another two types of threshold were applied
Table 3 Retrospective comparison of various diagnostic criteria of
acute cholangitis in a multicenter study in Japan
Charcot’s
triad (%)
TG07
(%)
The first draft
criteria (with
abdominal pain and
history of biliary
disease) (%)
TG13
(%)
Sensitivity 26.4 82.6 95.1 91.8
Specificity 95.9 79.8 66.3 77.7
Positive
rate in acute
cholecystitis
11.9 15.5 38.8 5.9
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Table 4 TG13 Diagnostic criteria for acute cholangitis
A. Systemic inflammation
A-1. Fever and/or shaking chills
A-2. Laboratory data: evidence of inflammatory response
B. Cholestasis
B-1. Jaundice
B-2. Laboratory data: abnormal liver function tests
C. Imaging
C-1. Biliary dilatation
C-2. Evidence of the etiology on imaging (stricture, stone, stent, etc.)
Suspected diagnosis: one item in A ? one item in either B or C
Definite diagnosis: one item in A, one item in B and one item in C
A-2 Abnormal white blood cell counts, increase of serum C-reactive protein levels, and other changes indicating inflammation
B-2 Increased serum ALP, r-GTP (GGT), AST, and ALT levels
Threshholds
A-1 Fever BT [38 C
A-2 Evidence of inflammatory response WBC (91,000/lL) \4, or [10
CRP (mg/dL) 31
B-1 Jaundice T-Bil32 (mg/dL)
B-2 Abnormal liver function tests ALP (IU) [1.5 9 STD*
cGTP (IU) [1.5 9 STD*
AST (IU) [1.5 9 STD*
ALT (IU) [1.5 9 STD*
Other factors which are helpful in diagnosis of acute cholangitis include abdominal pain (Right upper quadrant (RUQ) or upper abdominal) and a
history of biliary disease such as gallstones, previous biliary procedures, and placement of a biliary stent
In acute hepatitis, marked systematic inflammatory response is observed infrequently. Virological and serological tests are required when
differential diagnosis is difficult
ALP Alkaline phosphatase, r-GTP (GGT) r-glutamyltransferase,
AST aspartate aminotransferase, ALT alanine aminotransferase
* STD upper limit of normal value
Table 5 Comparisons of
various cut-offs for laboratory
testing results for the diagnosis
of acute cholangitis in Japan
STD upper limit of normal value
Thresholds for positivity of test
Adoption Limit of this
test (low)
Limit of this
test (high)
T-Bil (mg/dL) 32 Same Same
ALP (IU) [1.5 9 STD 3400 3500
cGTP (IU) [1.5 9 STD 3100 3150
AST (IU) [1.5 9 STD 350 3100
ALT (IU) [1.5 9 STD 350 3100
WBC (91,000/lL) \4, or [10 Same Same
CRP (mg/dL) 31 Same Same
BT [38 C Same Same
Sensitivity 91.8 % 93.0 % 92.7 %
Specificity 77.7 % 77.9 % 77.9 %
Positive rate in acute cholecystitis (n = 219) 5.9 % 9.1 % 8.7 %
552 J Hepatobiliary Pancreat Sci (2012) 19:548–556
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(Table 5). From the above results, it was considered
appropriate and practical that the threshold was set at 1.5
times the normal upper limit for the liver function test in
the particular facility.
Formulation of new severity assessment criteria
for acute cholangitis
Assessment of TG07 severity assessment criteria for acute
cholangitis
The use of TG07 severity assessment criteria in actual
clinical situations has shown that use of these criteria was
inefficient in separating moderate cases (Grade II) from
mild cases (Grade I) at the time of initial diagnosis. In
TG07, Grades II and I were only assessed after observation
of the initial treatment courses. In this treatment strategy,
urgent biliary drainage can be indicated for cases assessed
as ‘severe’, but provision of early biliary drainage is
impossible for cases as ‘moderate’. The present multicenter
analysis showed that many cases (46.8 %, 258 of 551
cases) of Grade II or I underwent urgent biliary drainage in
the same manner as Grade III. In these cases, differentia-
tion between grade II and Grade I was impossible, because
the definition of Grade II in TG07 was ambiguous
(Table 6).
Revision of TG07 severity assessment criteria for acute
cholangitis
Given these insufficiencies of TG07 in clinical practice, a
revision was sought which might improve severity assess-
ment strategies upon diagnosis in order to allow selection of
those patients who needed immediate source control of
infection. Since there had been no scientifically based defi-
nitions of ‘moderate cases’ except for the consensus-based
TG07 we needed a new definition of what constituted mod-
erate cases needing early source control in TG13.
To improve TG07 we examined items reported as pre-
dictive factors of poor prognosis among patients with acute
Table 6 Timing of biliary drainage among patients with acute cho-
langitis diagnosed with TG07—multicenter analysis of acute cho-
langitis for revision of TG07 severity criteria of acute cholangitis
Timing of drainage/
treatment for etiology
Grade III Grade II Grade I Total
Within 24 h 41 258
(Grade II or I)
297
24–48 h 9 54 0 63
After 48 h 20 130 12 162
Drainage (-) 2 3 96 101
Total 72 (11.6 %) 551 (88.4 %)
(Grade II or I)
623
Table 7 TG13 Severity assessment criteria for acute cholangitis
Grade III (Severe) acute cholangitis
‘Grade III’ acute cholangitis is defined as acute cholangitis that is associated with the onset of dysfunction at least in any one of the following
organs/systems
1. Cardiovascular dysfunction Hypotension requiring dopamine C5 lg/kg per min, or any dose of norepinephrine
2. Neurological dysfunction Disturbance of consciousness
3. Respiratory dysfunction PaO2/FiO2 ratio \300
4. Renal dysfunction Oliguria, serum creatinine [2.0 mg/dL
5. Hepatic dysfunction PT-INR [1.5
6. Hematological dysfunction Platelet count \1,00,000/mm3
Grade II (moderate) acute cholangitis
‘Grade II’ acute cholangitis is associated with any two of the following conditions:
1. Abnormal WBC count ([12,000/mm3, \4,000/mm3)
2. High fever (C39 C)
3. Age (C75 years)
4. Hyperbilirubinemia (total bilirubin C5 mg/dL)
5. Hypoalbuminemia (\STD 9 0.7)
Grade I (mild) acute cholangitis
‘Grade I’ acute cholangitis does not meet the criteria of ‘Grade III (severe)’ or ‘Grade II (moderate)’ acute cholangitis at initial diagnosis
Early diagnosis, early biliary drainage and/or treatment for etiology, and antimicrobial administration are fundamental treatment for acute
cholangitis classified not only ‘Grade III (severe)’ and ‘Grade II (moderate)’ but also Grade I (mild)
Therefore, it is recommended that patients with acute cholangitis who do not respond to the initial medical treatment (general supportive care and
antimicrobial therapy) undergo early biliary drainage or treatment for etiology
STD lower limit of normal value
J Hepatobiliary Pancreat Sci (2012) 19:548–556 553
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cholangitis and factors associated with the need for urgent
biliary drainage (Table 2). Furthermore, factors that
endoscopic gastroenterologists value in determining the
timing of biliary drainage were integrated except for the
factors that define Grade III cases (severe cases). Presence
or absence of endotoxemia and/or bacteremia, and malig-
nancy as etiology cannot be assessed upon the diagnosis of
acute cholangitis and were therefore not included. Medical
comorbidities such as diabetes mellitus and neurological
diseases were considered as severity factors; however, due
to their wide disease spectrum, it was decided that it was
impractical to include co-morbidity in TG13. The criteria
selected for moderate severity were leukocytosis high
fever, age [75 years, hyperbilirubinemia, and hypoalbu-
minemia. The presence of any two of the five positive
criteria will classify the disease as Grade II (moderate).
The revised assessment criteria for acute cholangitis are
shown in Table 7.
Assessment of TG13 severity assessment criteria for acute
cholangitis
We performed a multicenter analysis using the TG13
severity assessment criteria for acute cholangitis in real
clinical settings. Of the 623 cases of acute cholangitis
where severity grading was retrospectively made clear,
there were 72 Grade III cases (11.6 %), 216 Grade II cases
(34.7 %) and 335 Grade I cases (53.8 %). Furthermore, the
Grade II cases requiring urgent or early biliary drainage
accounted for 46 % of the acute cholangitis cases. An
examination of Grade I cases where biliary drainage had
been carried out within 24 h and within 48 h found 140
cases (41.8 %) and 181 cases (54.0 %), respectively. It was
surprising that so many patients with Grade I criteria had
undergone biliary drainage. However, on further analysis it
was found that almost all Grade I cases that had undergone
early biliary drainage were due to biliary obstruction such
as common duct stones. These types of interventions
accounted for 135 of 140 cases (94.8 %) within 24 h and
41 cases (100 %) within 48 h, respectively. The number of
Grade I cases that had undergone biliary drainage as an
urgent treatment to control infection were small (Table 8).
Of the 110 cases of acute cholangitis that met the
Charcot’s triad, 13 cases (11.8 %) have been classified as
Grade III, and 52 as Grade II (47.3 %), respectively. Fur-
thermore, approximately 80 % (59 of 72 cases) of Grade III
cases in TG13 failed to satisfy Charcot’s triad (Table 9).
Charcot’s triad was not found to be associated with disease
severity.
Discussion
The main goals of diagnostic and severity assessment cri-
teria are to allow early establishment of diagnosis and
selection of the most appropriate management plan for the
stage of the disease. This was attempted for acute cho-
langitis in TG07 where the guidelines were based on
available literature and input of experts at a consensus
conference held in Tokyo in 2006. At that meeting, diag-
nostic criteria were presented combining blood tests and
diagnostic imaging together with Charcot’s triad [23].
However, there is a report showing that the sensitivity was
low (63.9 %) for making a definite diagnosis of acute
cholangitis [7]. It is well established that guidelines need
periodic assessment and revision; however, in the case of
TG07 this was particularly so because of shortcomings that
became evident through application in clinical practice and
as a result of new information in the literature. As in TG07,
initial iterations were produced in Japan with modifications
incorporating the input of experts from around the world.
Table 8 Timing of biliary drainage among patients with acute cholangitis diagnosed with TG13—multicenter analysis of acute cholangitis for
revision of TG07 Severity assessment criteria for acute cholangitis
Timing of drainage/treatment for etiology Grade III Grade II Grade I Total
Within 24 h 41 116 140 (135) 297
24–48 h 9 13 41 (41) 63
After 48 h 20 48 94 162
Drainage (-) 2 39 60 101
Total 72 (11.6 %) 216 (34.7 %) 335 (53.8 %) 623
() indicates the number of cases that have early drainage and treatment of etiology
Table 9 TG13 Severity assessment criteria and Charcot’s triad
Severity grading of TG13 Charcot’s triad
Yes (n = 110) No (n = 513)
Grade III 13 (11.8 %) 59 (11.5 %)
Grade II 52 (47.3 %) 164 (32.0 %)
Grade I 45 (40.9 %) 290 (56.5 %)
554 J Hepatobiliary Pancreat Sci (2012) 19:548–556
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A particularly vexing problem in studies of acute cho-
langitis is how to set a gold standard for the disease against
which to compare diagnostic and severity grading criteria.
Unlike diseases such as acute cholecystitis there is no
organ or tissue with which absolute diagnosis of acute
cholangitis can be achieved pathologically. Therefore, a
gold standard must be set by other means. An important
step in generation of TG13 was to adopt the three gold
standard diagnostic criteria suggested in the literature and
by experience. This then permitted the gathering of a large
number of example cases by which to refine and judge the
adequacy of the new criteria. While this was an arduous
task it seems that the results support this approach in
dealing with these issues. Another novelty in our approach
is that the diagnostic criteria were not judged simply
against normal individuals but included patients with other
biliary tract diseases especially acute cholecystitis. This
increases the robustness of the criteria as a clinical tool.
The early iterations of the diagnostic criteria for TG13
included abdominal pain and a history of biliary tract dis-
ease; however, it was found that inclusion of these criteria
resulted in a schema with low specificity and a high false
positive rate in cases of acute cholecystitis. When these
variables were dropped the results improved dramatically.
It may seem odd to have diagnostic criteria which elimi-
nate abdominal pain as a symptom of acute cholangitis but
the benefit of eliminating confusion with other biliary tract
disease if pain is included outweighs any advantage of
including it.
The new TG13 diagnostic criteria have fewer variables
and are arranged in more logical categories. The thresholds
for laboratory tests have been selected to permit worldwide
use as they do not depend on absolute values but on 1.5
times the upper limit of normal of any laboratory. As such
these criteria should be amenable to use on handheld
devices further improving the ability to rapidly diagnose
the condition.
Ideally, a definitive diagnosis should be available at the
time of presentation. If the requirement for a definitive
diagnosis results in delay of biliary drainage with pro-
gression to more severe stages of the disease or death under
observation the purpose of a definitive diagnosis is sub-
verted. At the present state of knowledge our data suggest
that the decision to proceed to early biliary drainage can
and should be made on suspected diagnosis and severity
grading as outlined in the paper as both of these can be
determined at presentation. The effect of this strategy can
be determined as the criteria for diagnosis are evaluated in
the future.
The severity grading has also been revised based on new
information available in the literature. The criteria for
severe cases have not been modified but those in the
important moderate group have been updated. As noted all
five criteria in the moderate group are determinable at
presentation. This required the exclusion of a number of
criteria as outlined in the results.
In practice the diagnostic criteria and severity grading
would be used in tandem at the time of presentation. If a
patient fit the suspected criteria, severity grading would be
performed. Those falling into the moderate and severe
categories would be candidates for urgent biliary decom-
pression, while those in the mild category would be treated
initially with antibiotics. Many of the latter patients would
still have biliary drainage within the first 48 h for control of
the cause of acute cholangitis such as extraction of com-
mon duct stones.
A diagnosis of acute cholangitis has traditionally been
made by Charcot’s triad. According to several reports,
Charcot’s triad was observed for only 9 % except in cases
of acute cholangitis [8], but cases of acute cholangitis
presenting all of Charcot’s triad accounted for only
50–70 % [3, 8–14, 24–26]. We also continued to examine
the utility of Charcot’s triad because of the prominence of
this diagnostic triad in this disease. We found that Char-
cot’s triad shows very high specificity—the presence of the
Charcot’s triad strongly suggested the presence of acute
cholangitis. However, due to the low sensitivity, it is not
applicable in making a diagnosis of acute cholangitis. Also
as noted the triad was not associated with disease severity.
In summary TG13 presents new diagnostic and severity
grading systems based on a large patients base and a rea-
sonable gold standard. These criteria allow early diagnosis
and severity grading of the disease and should be clinically
useful in the management of this severe disease.
Conclusion
TG13 introduces a new standard for the diagnosis, severity
grading and management of acute cholangitis. As com-
pared with Charcot’s triad and TG07, validity of the
diagnostic criteria has been improved and severity assess-
ment criteria have become more suitable for clinical use.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
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